Poor labeling of Tc-99m red blood cells in vivo in a radionuclide intestinal bleeding study of a patient who had recently undergone frequent blood transfusions.
The authors report poor labeling of Tc-99m red blood cells (RBCs) in vivo in a radionuclide intestinal bleeding study of a patient who had recently undergone frequent blood transfusions. The existence of RBC antibodies, as a result of the recent blood transfusions in this patient, was one of the causes of the poor labeling. In radionuclide bleeding studies with patients with recent blood transfusion, Tc-99m HSA-D must be chosen instead of Tc-99m RBCs in vivo.
Kawabe
Joji
J
Department of Nuclear Medicine, Graduate School of Medicine, Osaka City University, Japan. kawabe@med.osaka-cu.ac.jp
Higashiyama
Shigeaki
S
Torii
Kenji
K
Okamura
Terue
T
Kotani
Jin
J
Kawamura
Etsushi
E
Ishizu
Hirotaka
H
Koyama
Koichi
K
Yamane
Takahisa
T
Shiomi
Susumu
S
D000328:Adult; D001803:Blood Transfusion; D004912:Erythrocytes; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000000981:diagnostic imaging*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013670:Sodium Pertechnetate Tc 99m; D013668:Technetium Tc 99m Aggregated Albumin; D016284:Technetium Tc 99m Pentetate; D014003:Tin Polyphosphates
D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D014003:Tin Polyphosphates; C057162:technetium Tc 99m DTPA HSA; D013670:Sodium Pertechnetate Tc 99m; D016284:Technetium Tc 99m Pentetate